BioSpace News Archive

Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration

Government

FDA’s 2027 Budget Proposes Permanent Rare Disease Vouchers, Easier Entry to Clinic

If the Trump administration’s proposal passes, the FDA’s budget will be more than $200 million bigger in 2027, with plans to launch new programs that expedite drug development, boost national security and promote “radical transparency.”

April 7, 2026

·

3 min read

·

Tristan Manalac

Immunology and inflammation

Amgen Seeks ‘Return to Growth’ for Tepezza as More Convenient Formulation Aces Phase 3

Sales of Amgen’s thyroid eye disease drug Tepezza have slowed, dipping 1% to $457 million in the fourth quarter of 2025.

April 7, 2026

·

3 min read

·

Tristan Manalac

Businessman drawing red circle to marking and select human icons , Human development or marketing focus customer target group.

Drug development

Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off

Sanofi has faced questions about the potential of lunsekimig in eczema, with executives calling the clinical trial a “measured risk.”

April 7, 2026

·

2 min read

·

Annalee Armstrong

Many various colored tablets and pills are stacked in shopping cart, percent signs are around. Concept of buying of medicines, online sales of medication, discounts and promotions in pharmacy

Drug pricing

AbbVie Puts Humira on TrumpRx at Steep Discount as Tariff Threat Solidifies

Humira will be available on TrumpRx at an 86% discount, according to media reports, as part of AbbVie’s deal with the White House to avoid tariffs. The news comes less than a week after the president announced up to 100% levies on pharma products.

April 7, 2026

·

1 min read

·

Tristan Manalac

Trendy halftone collage. Legislation concept, regulations, rules, law, authority, legal document, verdict. Hands holding a gavel with scales and regulation document. Vector illustration

FDA

FDA Seeks Expanded Authority To Regulate Postapproval Manufacturing Changes

Aiming to protect patients, the FDA sent lawmakers a wish list of legislative proposals intended to clarify and expand its oversight of updates to approved drug production processes.

April 7, 2026

·

2 min read

·

Nick Paul Taylor

businesswoman drawing big fish on the wall

Mergers & acquisitions

Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis

The acquisition of Tubulis GmbH—Gilead Sciences’ latest of the year after buying Arcellx and Ouro Medicines—brings into the fold a novel ovarian cancer candidate that has demonstrated promising mid-stage data.

April 7, 2026

·

2 min read

·

Heather McKenzie

Press Releases

TGH Cancer Institute and USF Health Morsani College of Medicine Convene International Scientific Leaders for the “Microbes, Genes & Cancer” Symposium

April 7, 2026

·

9 min read

Press Releases

DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting